OCULAR THERAPEUTIX, INC Interest Expense
OCULAR THERAPEUTIX, INC (OCUL) reported Interest Expense of $4.05 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-07
- OCULAR THERAPEUTIX, INC interest expense for the quarter ending 2024-03-31 was $4.05M, a 129.13% increase year-over-year.
- OCULAR THERAPEUTIX, INC interest expense for the quarter ending 2023-12-31 was $4.15M, a 124.74% increase year-over-year.
- OCULAR THERAPEUTIX, INC interest expense for the quarter ending 2023-09-30 was $3.43M, a 90.65% increase year-over-year.
- OCULAR THERAPEUTIX, INC interest expense for the quarter ending 2023-06-30 was $1.99M, a 17.39% increase year-over-year.
- OCULAR THERAPEUTIX, INC interest expense for fiscal 2023 was $11.34M, a 61.46% increase from fiscal 2022.
- OCULAR THERAPEUTIX, INC interest expense for fiscal 2022 was $7.02M, a 5.26% increase from fiscal 2021.
- OCULAR THERAPEUTIX, INC interest expense for fiscal 2021 was $6.67M, a 1.43% decline from fiscal 2020.
- OCULAR THERAPEUTIX, INC interest expense for fiscal 2020 was $6.77M, a 10.93% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $4.05M 10-Q · filed 2024-05-07 | $8.20M derived: sum of 2 quarters · filed 2024-05-07 | $11.63M derived: sum of 3 quarters · filed 2024-05-07 | $13.62M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $7.58M derived: sum of 2 quarters · filed 2024-03-11 | $9.57M derived: sum of 3 quarters · filed 2024-03-11 | $11.34M 10-K · filed 2024-03-11 |
| 2023-09-30 | $3.43M 10-Q · filed 2023-11-07 | $5.42M derived: sum of 2 quarters · filed 2023-11-07 | $7.19M 10-Q · filed 2023-11-07 | $9.03M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $1.99M 10-Q · filed 2023-08-07 | $3.76M 10-Q · filed 2023-08-07 | $5.61M derived: sum of 3 quarters · filed 2024-05-07 | $7.40M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $1.77M 10-Q · filed 2024-05-07 | $3.62M derived: sum of 2 quarters · filed 2024-05-07 | $5.41M derived: sum of 3 quarters · filed 2024-05-07 | $7.11M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $3.64M derived: sum of 2 quarters · filed 2024-03-11 | $5.34M derived: sum of 3 quarters · filed 2024-03-11 | $7.02M 10-K · filed 2024-03-11 |
| 2022-09-30 | $1.80M 10-Q · filed 2023-11-07 | $3.49M derived: sum of 2 quarters · filed 2023-11-07 | $5.17M 10-Q · filed 2023-11-07 | $6.86M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | $1.70M 10-Q · filed 2023-08-07 | $3.38M 10-Q · filed 2023-08-07 | $5.06M derived: sum of 3 quarters · filed 2024-03-11 | $6.72M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | $1.68M 10-Q · filed 2023-05-08 | $3.36M derived: sum of 2 quarters · filed 2024-03-11 | $5.02M derived: sum of 3 quarters · filed 2024-03-11 | $6.68M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $3.34M derived: sum of 2 quarters · filed 2024-03-11 | $4.99M derived: sum of 3 quarters · filed 2024-03-11 | $6.67M 10-K · filed 2024-03-11 |
| 2021-09-30 | $1.66M 10-Q · filed 2022-11-07 | $3.31M derived: sum of 2 quarters · filed 2022-11-07 | $4.99M 10-Q · filed 2022-11-07 | $6.72M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $1.66M 10-Q · filed 2022-08-08 | $3.33M 10-Q · filed 2022-08-08 | $5.06M derived: sum of 3 quarters · filed 2023-03-06 | $6.78M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $1.68M 10-Q · filed 2022-05-09 | $3.40M derived: sum of 2 quarters · filed 2023-03-06 | $5.12M derived: sum of 3 quarters · filed 2023-03-06 | $6.81M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $3.44M derived: sum of 2 quarters · filed 2023-03-06 | $5.13M derived: sum of 3 quarters · filed 2023-03-06 | $6.77M 10-K · filed 2023-03-06 |
| 2020-09-30 | $1.72M 10-Q · filed 2021-11-08 | $3.41M derived: sum of 2 quarters · filed 2021-11-08 | $5.04M 10-Q · filed 2021-11-08 | $6.85M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $1.69M 10-Q · filed 2021-08-09 | $3.33M 10-Q · filed 2021-08-09 | $5.13M derived: sum of 3 quarters · filed 2022-02-28 | $6.78M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.63M 10-Q · filed 2021-05-05 | $3.44M derived: sum of 2 quarters · filed 2022-02-28 | $5.09M derived: sum of 3 quarters · filed 2022-02-28 | $6.72M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $3.46M derived: sum of 2 quarters · filed 2022-02-28 | $5.08M derived: sum of 3 quarters · filed 2022-02-28 | $6.10M 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.65M 10-Q · filed 2020-11-05 | $3.28M derived: sum of 2 quarters · filed 2020-11-05 | $4.30M 10-Q · filed 2020-11-05 | $4.67M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $1.63M 10-Q · filed 2020-08-07 | $2.65M 10-Q · filed 2020-08-07 | $3.02M derived: sum of 3 quarters · filed 2020-08-07 | $3.44M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $1.02M 10-Q · filed 2020-05-08 | $1.39M derived: sum of 2 quarters · filed 2020-05-08 | $1.82M derived: sum of 3 quarters · filed 2020-05-08 | $2.27M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $798.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.25M derived: sum of 3 quarters · filed 2020-03-12 | $1.74M 10-K · filed 2020-03-12 |
| 2018-09-30 | $424.00K 10-Q · filed 2019-11-12 | $879.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.36M 10-Q · filed 2019-11-12 | $1.85M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $455.00K 10-Q · filed 2019-08-07 | $941.00K 10-Q · filed 2019-08-07 | $1.43M derived: sum of 3 quarters · filed 2020-03-12 | $1.92M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $486.00K 10-Q · filed 2019-05-10 | $976.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.47M derived: sum of 3 quarters · filed 2020-03-12 | $1.94M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $981.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.45M derived: sum of 3 quarters · filed 2020-03-12 | $1.89M 10-K · filed 2020-03-12 |
| 2017-09-30 | $491.00K 10-Q · filed 2018-11-07 | $959.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.40M 10-Q · filed 2018-11-07 | $1.82M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $468.00K 10-Q · filed 2018-08-07 | $911.00K 10-Q · filed 2018-08-07 | $1.33M derived: sum of 3 quarters · filed 2019-03-07 | $1.75M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $443.00K 10-Q · filed 2018-05-08 | $861.00K derived: sum of 2 quarters · filed 2019-03-07 | $1.29M derived: sum of 3 quarters · filed 2019-03-07 | $1.71M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $844.00K derived: sum of 2 quarters · filed 2019-03-07 | $1.26M derived: sum of 3 quarters · filed 2019-03-07 | $1.68M 10-K · filed 2019-03-07 |
| 2016-09-30 | $426.00K 10-Q · filed 2017-11-07 | $844.00K derived: sum of 2 quarters · filed 2017-11-07 | $1.26M 10-Q · filed 2017-11-07 | $1.67M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $418.00K 10-Q · filed 2016-08-09 | $836.00K 10-Q · filed 2017-08-08 | $1.24M derived: sum of 3 quarters · filed 2018-03-08 | $1.65M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $418.00K 10-Q · filed 2017-05-05 | $826.00K derived: sum of 2 quarters · filed 2018-03-08 | $1.23M derived: sum of 3 quarters · filed 2018-03-08 | $1.64M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $814.00K derived: sum of 2 quarters · filed 2018-03-08 | $1.22M derived: sum of 3 quarters · filed 2018-03-08 | $1.72M 10-K · filed 2018-03-08 |
| 2015-09-30 | $406.00K 10-Q · filed 2016-11-09 | $811.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.32M 10-Q · filed 2016-11-09 | $1.72M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $405.00K 10-Q · filed 2016-08-09 | $910.00K 10-Q · filed 2016-08-09 | $1.32M derived: sum of 3 quarters · filed 2017-03-10 | $1.73M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | $505.00K 10-Q · filed 2016-05-10 | $912.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.32M derived: sum of 3 quarters · filed 2017-03-10 | $1.58M derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | $407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $819.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.08M derived: sum of 3 quarters · filed 2017-03-10 | $1.12M 10-K · filed 2017-03-10 |
| 2014-09-30 | $412.00K 10-Q · filed 2015-11-10 | $669.00K derived: sum of 2 quarters · filed 2015-11-10 | $712.00K 10-Q · filed 2015-11-10 | $803.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $257.00K 10-Q · filed 2015-08-10 | $300.00K 10-Q · filed 2015-08-10 | $391.00K derived: sum of 3 quarters · filed 2016-03-10 | $485.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $43.00K 10-Q · filed 2015-05-15 | $134.00K derived: sum of 2 quarters · filed 2016-03-10 | $228.00K derived: sum of 3 quarters · filed 2016-03-10 | $335.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $185.00K derived: sum of 2 quarters · filed 2016-03-10 | $292.00K derived: sum of 3 quarters · filed 2016-03-10 | $441.00K 10-K · filed 2016-03-10 |
| 2013-09-30 | $94.00K 10-Q · filed 2014-11-12 | $201.00K derived: sum of 2 quarters · filed 2014-11-12 | $350.00K 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $107.00K 10-Q · filed 2014-08-29 | $256.00K 10-Q · filed 2014-08-29 | ||
| 2012-12-31 | $377.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |